| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO And Cbo | Chief Financial Officer | Executive Vice President &CFO
3 companies
Henderson Molly is a CFO And Cbo at Phathom Pharmaceuticals, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 7, 2025 | PHAT Phathom Pharmaceuticals, Inc. | CFO And Cbo | Sell | 3,678 | $4.55 | $16,739.68 | -3.9% | +77.8% | +137.2% | |
| Jan 21, 2025 | PHAT Phathom Pharmaceuticals, Inc. | CFO And Cbo | Sell | 6,583 | $6.59 | $43,370.78 | -6.6% | -42.6% | +100.4% | |
| Dec 19, 2024 | PHAT Phathom Pharmaceuticals, Inc. | CFO And Cbo | Sell | 1,291 | $8.00 | $10,328.00 | -1.3% | -22.3% | +124.2% | |
| Jul 15, 2024 | PHAT Phathom Pharmaceuticals, Inc. | CFO And Cbo | Sell | 4,325 | $11.72 | $50,689.00 | -4.2% | +20.6% | -32.6% | |
| Apr 8, 2024 | PHAT Phathom Pharmaceuticals, Inc. | CFO And Cbo | Sell | 3,435 | $11.10 | $38,128.50 | -3.5% | -6.1% | -61.7% | |
| Jan 19, 2024 | PHAT Phathom Pharmaceuticals, Inc. | CFO And Cbo | Sell | 6,307 | $7.75 | $48,900.06 | -6.0% | +26.6% | -7.1% | |
| Nov 20, 2023 | PHAT Phathom Pharmaceuticals, Inc. | CFO And Cbo | Sell | 2,127 | $7.24 | $15,402.67 | -2.0% | +37.2% | +26.5% | |
| Nov 1, 2023 | PHAT Phathom Pharmaceuticals, Inc. | CFO And Cbo | Sell | 12,492 | $8.88 | $110,870.75 | -5.3% | -28.9% | +78.5% | |
| Jun 2, 2023 | PHAT Phathom Pharmaceuticals, Inc. | CFO And Cbo | Sell | 1,960 | $11.41 | $22,367.72 | -2.8% | +23.4% | -19.2% | |
| May 22, 2023 | PHAT Phathom Pharmaceuticals, Inc. | CFO And Cbo | Sell | 2,110 | $12.87 | $27,164.98 | -2.9% | +11.6% | -20.4% |